REVIEWING THE DYSREGULATION OF ADAMTS13 AND VWF IN SEPSIS

被引:2
|
作者
Madarati, Hasam
Singh, Kanwal
Sparring, Taylor
Andrisani, Peter
Liaw, Patricia C.
Fox-Robichaud, Alison E.
Kretz, Colin A.
机构
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada
来源
SHOCK | 2024年 / 61卷 / 02期
关键词
ADAMTS13; Von Willebrand factor; sepsis; disseminated intravascular coagulation; hemostasis; coagulation; cardiovascular disease; thrombotic microangiopathies; thrombotic thrombocytopenia purpura; Von Willebrand disease; inflammation; neutrophil extracellular traps; alpha-defensin; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; INTRAVASCULAR COAGULATION; INFLAMMATORY CYTOKINES; CLINICAL-IMPLICATIONS; ENDOTHELIAL-CELLS; FACTOR PROPEPTIDE;
D O I
10.1097/SHK.0000000000002291
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Sepsis is defined as a life-threatening organ dysfunction caused by excessive host response to infection, and represents the most common cause of in-hospital deaths. Sepsis accounts for 30% of all critically ill patients in the intensive care unit (ICU), and has a global mortality rate of 20%. Activation of blood coagulation during sepsis and septic shock can lead to disseminated intravascular coagulation, which is characterized by microvascular thrombosis. Von Willebrand factor (VWF) and ADAMTS13 are two important regulators of blood coagulation that may be important links between sepsis and mortality in the ICU. Herein we review our current understanding of VWF and ADAMTS13 in sepsis and other critical illnesses and discuss their contribution to disease pathophysiology, their use as markers of severe illness, and potential targets for new therapeutic development.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 50 条
  • [21] The effects of shear stress on the interaction between ADAMTS13 and VWF
    Bai, Yichen
    Mi, Li-Zhi
    CHINESE SCIENCE BULLETIN-CHINESE, 2022, 67 (30): : 3520 - 3530
  • [22] VWF and ADAMTS13 behavior in estradiol-treated HUVEC
    Powazniak, Yanina
    Catalina Kempfer, Ana
    Calderazzo Pereyra, Julio Cesar
    Paiva Palomino, Juvenal
    Angela Lazzari, Maria
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (02) : 140 - 147
  • [23] How ADAMTS13 recognises and cleaves the VWF scissile bond
    Lane, D. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 6 - 6
  • [24] High VWF, low ADAMTS13 puts women at risk
    Bender, Markus
    BLOOD, 2012, 119 (06) : 1329 - 1330
  • [25] ADAMTS13 in nephrology [ADAMTS13 in der Nephrologie]
    Bockmeyer C.L.
    Modde F.
    Becker J.U.
    Der Nephrologe, 2013, 8 (1): : 69 - 70
  • [26] In vitro and in vivo cleavage of human recombinant VWF (rVWF) by ADAMTS13
    Varadi, K.
    Vejda, S.
    Schreiner, J.
    Gritsch, H.
    Muchitsch, E. -M.
    Rottensteiner, H.
    HAEMOPHILIA, 2010, 16 : 153 - 153
  • [27] REDUCED ADAMTS13 RESPONSE IN PEDIATRIC SURGICAL SEPSIS
    Fink, Darla
    Adams, Phillip
    Canna, Scott
    Carcillo, Joseph
    Cladis, Franklyn
    Fink, Ericka
    Kernan, Kate
    CRITICAL CARE MEDICINE, 2024, 52
  • [28] ADAMTS13/vWF Regulates the Efficacy of tPA in Ischemic Stroke Patients
    Deng Wenjun
    Liu, Kai
    Fisher, Lindsay
    Chou, Richard
    Bunda, Bridget
    Wang, Andrew
    D'Souza, Erica
    McMullin, David
    Buonanno, Ferdinando
    Ferdinando, Lo
    Eng, H.
    Ning MingMing
    STROKE, 2019, 50
  • [29] Cleavage of Recombinant and Plasma-Derived VWF by Human ADAMTS13
    Rottensteiner, Hanspeter
    Varadi, Katalin
    Vejda, Susanne
    Ehrlich, Hartmut J.
    Scheiflinger, Friedrich
    Schwarz, Hans Peter
    Turecek, Peter
    BLOOD, 2010, 116 (21) : 608 - 608
  • [30] VWF and ADAMTS13 Biomarkers for increased Risk of Stroke and Myocardial Infarction
    Ruchalla, Elke
    TRANSFUSIONSMEDIZIN, 2012, 2 (03) : 129 - 129